Search results
Dow Jones Futures: New Stock Market King Nvidia Faces This Risk; ELF, Palantir Rally
Investor's Business Daily· 1 hour agoStocks Near Buy Points Elf Beauty stock jumped 9.4% to 213.73, clearing a 202.58 cup-with-handle buy...
Retire Rich: 3 Powerhouse Stocks to Buy for Long-Term Stability
InvestorPlace· 8 hours agoStocks with extended outlook and stability can guide long-term investors, especially when...
Greif, Inc. (GEF): What Makes Bank of America Optimistic About This Stock?
Insider Monkey via Yahoo Finance· 4 hours agoWe recently compiled a list of the 10 Stocks Receiving a Massive Vote of Approval From Wall Street...
Oil Steadies Ahead of US Stockpile Data as Volatility Declines
Bloomberg via Yahoo Finance· 30 minutes ago...Services After CyberattackWhat to Know About the Deadly Flesh-Eating Bacteria Spreading in...
Stock Market Today: Stocks extend record run; retail sales disappoint
TheStreet.com· 2 days agoStocks finished higher, with the S&P 500 and the Nasdaq both posting fresh record closes as AI chipmaker Nvidia took the crown as the world's most valuable public company. The Dow Jones Industrial ...
European Stocks Struggle to Build on US Tech Rally: Markets Wrap
Bloomberg via Yahoo News· 7 hours agoMost Read from BloombergCar Dealerships Across US...Bacteria Spreading in JapanNvidia’s 591,078%...
Dell Stock Extends Rally. Wall Street Is Bullish on the AI Servers.
Barrons.com· 1 day agoSTOCKSTOWATCHTODAY BLOG Dell Technologies stock is up sharply for the second straight session, amid...
Stocks Show Modest Gains As S&P 500 Hits All-Time High; Nvidia Reaches Two Milestones (Live Update)
Investor's Business Daily· 1 day agoWainwright & Co. raised its price target to 26 from 19 and maintained its buy rating on the biotech ...
Ukraine war latest: Russia intensifies attacks near Toretsk, Donetsk Oblast
Kyiv Independent via Yahoo News· 6 hours agoThe tensions between the military bloc and Moscow have been mounting since the West threw its...
ADC Therapeutics director Bizzari sells $20,215 in shares By Investing.com
Investing.com· 4 hours agoJean-Pierre Bizzari, a director at ADC Therapeutics SA (NYSE:ADCT), has sold 6,995 shares of the...